NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus
- PMID: 23100627
- PMCID: PMC3704198
- DOI: 10.1126/scitranslmed.3004801
NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of tolerance to self nucleic acids. The source of autoantigen that drives disease onset and progression is unclear. A candidate source of autoantigen is the neutrophil extracellular trap (NET), which releases nucleic acids into the extracellular environment, generating a structure composed of DNA coated with antimicrobial proteins. On the basis of in vitro and patient correlative studies, several groups have suggested that NETs may provide lupus autoantigens. The observation that NET release (NETosis) relies on activity of the phagocyte NADPH (reduced form of nicotinamide adenine dinucleotide phosphate) oxidase (Nox2) in neutrophils of both humans and mice provided a genetic strategy to test this hypothesis in vivo. Therefore, we crossed an X-linked nox2 null allele onto the lupus-prone MRL.Fas(lpr) genetic background and assessed immune activation, autoantibody generation, and SLE pathology. Counter to the prevailing hypothesis, Nox2-deficient lupus-prone mice had markedly exacerbated lupus, including increased spleen weight, increased renal disease, and elevated and altered autoantibody profiles. Moreover, heterozygous female mice, which have Nox2 deficiency in 50% of neutrophils, also had exacerbated lupus and altered autoantibody patterns, suggesting that failure to undergo normal Nox2-dependent cell death may result in release of immunogenic self-constituents that stimulate lupus. Our results indicate that NETosis does not contribute to SLE in vivo; instead, Nox2 acts to inhibit disease pathogenesis, making this enzyme an important target for further study and a candidate for therapeutic intervention.
Figures




Comment in
-
Connective tissue diseases: NET loss implicates Nox2 in SLE.Nat Rev Rheumatol. 2012 Dec;8(12):692. doi: 10.1038/nrrheum.2012.201. Epub 2012 Nov 13. Nat Rev Rheumatol. 2012. PMID: 23147905 No abstract available.
Similar articles
-
Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus.PLoS One. 2013 Oct 18;8(10):e78459. doi: 10.1371/journal.pone.0078459. eCollection 2013. PLoS One. 2013. PMID: 24205237 Free PMC article.
-
Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation.Arthritis Res Ther. 2018 Nov 12;20(1):254. doi: 10.1186/s13075-018-1749-y. Arthritis Res Ther. 2018. PMID: 30419963 Free PMC article.
-
Sleep fragmentation in mice induces nicotinamide adenine dinucleotide phosphate oxidase 2-dependent mobilization, proliferation, and differentiation of adipocyte progenitors in visceral white adipose tissue.Sleep. 2014 May 1;37(5):999-1009. doi: 10.5665/sleep.3678. Sleep. 2014. PMID: 24790279 Free PMC article.
-
[Research advances in the role of neutrophil extracellular traps in childhood-onset systemic lupus erythematosus].Zhongguo Dang Dai Er Ke Za Zhi. 2018 Mar;20(3):251-254. doi: 10.7499/j.issn.1008-8830.2018.03.016. Zhongguo Dang Dai Er Ke Za Zhi. 2018. PMID: 29530128 Free PMC article. Review. Chinese.
-
Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis.Curr Opin Rheumatol. 2012 Sep;24(5):441-50. doi: 10.1097/BOR.0b013e3283546703. Curr Opin Rheumatol. 2012. PMID: 22617827 Review.
Cited by
-
Connective tissue diseases: NET loss implicates Nox2 in SLE.Nat Rev Rheumatol. 2012 Dec;8(12):692. doi: 10.1038/nrrheum.2012.201. Epub 2012 Nov 13. Nat Rev Rheumatol. 2012. PMID: 23147905 No abstract available.
-
IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation.JCI Insight. 2018 Aug 9;3(15):e120798. doi: 10.1172/jci.insight.120798. eCollection 2018 Aug 9. JCI Insight. 2018. PMID: 30089723 Free PMC article.
-
Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus.J Rheumatol. 2020 Nov 1;47(11):1652-1660. doi: 10.3899/jrheum.190875. Epub 2019 Dec 15. J Rheumatol. 2020. PMID: 31839592 Free PMC article.
-
Altered Mitochondrial Homeostasis during Systemic Lupus Erythematosus Impairs Neutrophil Extracellular Trap Formation Rendering Neutrophils Ineffective at Combating Staphylococcus aureus.J Immunol. 2022 Jan 15;208(2):454-463. doi: 10.4049/jimmunol.2100752. Epub 2021 Dec 20. J Immunol. 2022. PMID: 34930781 Free PMC article.
-
Extracellular DNA and autoimmune diseases.Cell Mol Immunol. 2018 Aug;15(8):746-755. doi: 10.1038/cmi.2017.136. Epub 2018 Mar 19. Cell Mol Immunol. 2018. PMID: 29553134 Free PMC article. Review.
References
-
- Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006;25:417–428. - PubMed
-
- Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cells. Cell. 2010;140:619–630. - PubMed
-
- Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet. 1998;19:56–59. - PubMed
-
- Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, Nagata S. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004;304:1147–1150. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous